SMi’s 2013 RNA Therapeutics conference will look to discuss and share some of the latest findings and research in the field of RNAi technologies and the delivery mechanisms by which these therapies are administered to their target tissues.
Developing an understanding in how Epigenetic mechanisms can be used to alter gene expression is undoubtedly a prime target for the development of compounds which offer the ability to alter the processes of translation of a peptide. SMi’s 2013 RNA Therapeutics conference offers the chance to meet the industry leaders in this field and provides the perfect opportunity to network and identify new strategies for RNAi development and application.
KEY REASONS TO ATTEND
Identify new delivery technologies which enhance the efficacy and bioavailability of your compounds for the appropriate tissue
Discover new approaches in the field of RNAi technologies
Evaluate the current landscape with respect to the current technologies and how these are being applied
Network with some of the industry leaders within the field of RNA therapeutics
Overcome the challenges of developing RNAi technologies and the mechanisms by which they alter gene expression
Visit our website here to register: http://www.smi-online.co.uk/goto/2013rna33.asp
Alternatively Contact Fateja Begum on telephone +44 (0) 20 7827 6184 or email on email@example.com